Trial Profile
Safety of the Certolizumab-pegol use during Rheumatoid-arthritis pregnancies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2018
Price :
$35
*
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 13 Jul 2018 New trial record
- 16 Jun 2018 Results assessing safety of Certolizumab-pegol, presented at the 19th Annual Congress of the European League Against Rheumatism